Revenue reaccelerated to $154.3M in 2026Q3 (up 14.0% year over year) while operating margin improved to 9.4% from 3.4% at the 2024Q4 trough, though the margin remains modest for a business with a 44.5% gross margin.
Proto Labs, Inc. (PRLB) annual income statement — 17-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|
| Sales/Revenue | 579.49M | 533.13M | 500.89M | 503.88M | 488.4M | 488.1M | 434.39M | 458.73M | 445.6M | 344.49M | 298.06M | 264.11M | 209.58M | 163.11M | 125.99M | 98.94M | 64.92M | 43.83M |
| Revenue Growth % | 11.79% | 6.44% | -0.59% | 3.17% | 0.06% | 12.36% | -5.3% | 2.95% | 29.35% | 15.58% | 12.85% | 26.02% | 28.49% | 29.46% | 27.34% | 52.4% | 48.11% | - |
| Cost of Goods Sold | 317.52M | 295.99M | 277.69M | 281.88M | 272.93M | 265.41M | 216.57M | 223.44M | 206.92M | 150.65M | 131.12M | 109.7M | 81.18M | 61.41M | 49.85M | 39.32M | 25.44M | 18.56M |
| COGS % of Revenue | - | 55.52% | 55.44% | 55.94% | 55.88% | 54.38% | 49.86% | 48.71% | 46.44% | 43.73% | 43.99% | 41.54% | 38.73% | 37.65% | 39.57% | 39.75% | 39.19% | 42.34% |
| Gross Profit | 261.97M | 237.14M | 223.2M | 221.99M | 215.47M | 222.69M | 217.83M | 235.29M | 238.68M | 193.84M | 166.94M | 154.4M | 128.4M | 101.7M | 76.14M | 59.62M | 39.48M | 25.27M |
| Gross Margin % | 45.21% | 44.48% | 44.56% | 44.06% | 44.12% | 45.62% | 50.14% | 51.29% | 53.56% | 56.27% | 56.01% | 58.46% | 61.27% | 62.35% | 60.43% | 60.25% | 60.81% | 57.66% |
| Gross Profit Growth % | - | 6.24% | 0.54% | 3.03% | -3.24% | 2.23% | -7.42% | -1.42% | 23.13% | 16.12% | 8.12% | 20.25% | 26.25% | 33.58% | 27.72% | 51.02% | 56.19% | - |
| Operating Expenses | 217.17M | 210.94M | 197.7M | 193.61M | 188.52M | 194.85M | 157.99M | 155.43M | 149.78M | 121.62M | 105.17M | 87.05M | 67.37M | 50.4M | 41.19M | 32.75M | 22.78M | 17.37M |
| OpEx % of Revenue | - | 39.57% | 39.47% | 38.42% | 38.6% | 39.92% | 36.37% | 33.88% | 33.61% | 35.3% | 35.29% | 32.96% | 32.15% | 30.9% | 32.69% | 33.1% | 35.09% | 39.62% |
| Selling, General & Admin | 172.2M | 168.13M | 156.41M | 153.48M | 150.3M | 150.61M | 121.05M | 122.74M | 121.05M | 98.06M | 82.78M | 68.7M | 50.77M | 38.54M | 32.05M | 27.52M | 18.5M | 14.23M |
| SG&A % of Revenue | - | 31.54% | 31.23% | 30.46% | 30.77% | 30.86% | 27.87% | 26.76% | 27.16% | 28.46% | 27.77% | 26.01% | 24.22% | 23.63% | 25.44% | 27.82% | 28.49% | 32.46% |
| Research & Development | 42.67M | 42.81M | 41.3M | 40.13M | 38.22M | 44.24M | 36.94M | 32.69M | 28.73M | 23.56M | 22.39M | 18.35M | 16.61M | 11.86M | 9.14M | 5.22M | 4.28M | 3.14M |
| R&D % of Revenue | - | 8.03% | 8.24% | 7.97% | 7.83% | 9.06% | 8.5% | 7.13% | 6.45% | 6.84% | 7.51% | 6.95% | 7.92% | 7.27% | 7.25% | 5.28% | 6.59% | 7.16% |
| Other Operating Expenses | 1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 44.8M | 26.2M | 25.5M | 28.38M | 26.95M | 27.84M | 59.84M | 79.86M | 88.9M | 72.23M | 61.77M | 67.15M | 60.53M | 51.3M | 34.95M | 26.87M | 16.7M | 7.91M |
| Operating Margin % | 7.73% | 4.91% | 5.09% | 5.63% | 5.52% | 5.7% | 13.77% | 17.41% | 19.95% | 20.97% | 20.72% | 25.42% | 28.88% | 31.45% | 27.74% | 27.16% | 25.72% | 18.04% |
| Operating Income Growth % | - | 2.77% | -10.17% | 5.33% | -3.2% | -53.47% | -25.07% | -10.17% | 23.08% | 16.93% | -8.02% | 10.94% | 17.99% | 46.8% | 30.06% | 60.9% | 111.19% | - |
| EBITDA | 77.19M | 60.02M | 61.3M | 65.91M | 66.37M | 68.33M | 92.43M | 110.72M | 115.65M | 90.7M | 79.25M | 81.28M | 71.67M | 58.87M | 41.03M | 31.13M | 20.18M | 10.81M |
| EBITDA Margin % | 13.32% | 11.26% | 12.24% | 13.08% | 13.59% | 14% | 21.28% | 24.14% | 25.95% | 26.33% | 26.59% | 30.77% | 34.19% | 36.09% | 32.56% | 31.47% | 31.09% | 24.67% |
| EBITDA Growth % | 35.26% | -2.1% | -6.99% | -0.7% | -2.86% | -26.08% | -16.52% | -4.26% | 27.51% | 14.45% | -2.49% | 13.41% | 21.74% | 43.49% | 31.78% | 54.26% | 86.63% | - |
| D&A (Non-Cash Add-back) | 32.39M | 33.81M | 35.81M | 37.53M | 39.42M | 40.49M | 32.59M | 30.86M | 26.75M | 18.47M | 17.48M | 14.13M | 11.14M | 7.57M | 6.08M | 4.26M | 3.48M | 2.91M |
| EBIT | 48.9M | 31.06M | 24.87M | 29.05M | -97.88M | 40.18M | 62.95M | 81.19M | 91.66M | 74.44M | 64.22M | 67.86M | 60.53M | 51.58M | 34.97M | 26.75M | 15.71M | 7.39M |
| Net Interest Income | 2.73M | 0 | 5.2M | 2.2M | 1M | 200K | 1.4M | 2.1M | 1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.73M | 0 | 5.4M | 3.3M | 1M | 200K | 1.4M | 2.1M | 1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 200K | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.48M | 4.86M | -824K | -430K | -124.82M | 12.35M | 3.11M | 1.34M | 2.76M | 2.21M | 2.45M | 712K | 3K | 279K | 23K | -114K | -986K | -517K |
| Pretax Income | 48.28M | 31.06M | 24.67M | 27.95M | -97.88M | 40.18M | 62.95M | 81.19M | 91.66M | 74.44M | 64.22M | 67.86M | 60.53M | 51.58M | 34.97M | 26.75M | 15.71M | 7.39M |
| Pretax Margin % | 8.33% | 5.83% | 4.93% | 5.55% | -20.04% | 8.23% | 14.49% | 17.7% | 20.57% | 21.61% | 21.55% | 25.69% | 28.88% | 31.62% | 27.76% | 27.04% | 24.2% | 16.86% |
| Income Tax | 13.26M | 9.82M | 8.08M | 10.73M | 5.58M | 6.81M | 12.08M | 17.54M | 15.07M | 22.66M | 21.51M | 21.35M | 18.9M | 16.3M | 10.94M | 8.78M | 4.76M | 3.17M |
| Effective Tax Rate % | 27.46% | 31.62% | 32.75% | 38.39% | -5.71% | 16.95% | 19.19% | 21.6% | 16.44% | 30.44% | 33.5% | 31.46% | 31.22% | 31.6% | 31.3% | 32.83% | 30.31% | 42.86% |
| Net Income | 35.02M | 21.24M | 16.59M | 17.22M | -103.46M | 33.37M | 50.87M | 63.66M | 76.59M | 51.78M | 42.71M | 46.51M | 41.63M | 35.28M | 24.02M | 17.97M | 10.95M | 4.22M |
| Net Margin % | 6.04% | 3.98% | 3.31% | 3.42% | -21.18% | 6.84% | 11.71% | 13.88% | 17.19% | 15.03% | 14.33% | 17.61% | 19.87% | 21.63% | 19.07% | 18.16% | 16.87% | 9.63% |
| Net Income Growth % | 136.04% | 28.01% | -3.64% | 116.64% | -410.03% | -34.39% | -20.09% | -16.89% | 47.92% | 21.24% | -8.18% | 11.72% | 18.02% | 46.83% | 33.68% | 64.11% | 159.32% | - |
| Net Income (Continuing) | 35.02M | 21.24M | 16.59M | 17.22M | -103.46M | 33.37M | 50.87M | 63.66M | 76.59M | 51.78M | 42.71M | 46.51M | 41.63M | 35.28M | 24.02M | 17.97M | 10.95M | 4.22M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.43 | 0.88 | 0.66 | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 | 2.81 | 1.93 | 1.61 | 1.77 | 1.60 | 1.36 | 0.98 | 1.36 | 0.22 | 0.00 |
| EPS Growth % | 133.09% | 33.33% | 0% | 117.51% | -411.57% | -35.98% | -19.57% | -16.37% | 45.6% | 19.88% | -9.04% | 10.63% | 17.65% | 38.78% | -27.94% | 518.18% | - | - |
| EPS (Basic) | - | 0.89 | 0.66 | 0.66 | -3.77 | 1.21 | 1.90 | 2.37 | 2.84 | 1.94 | 1.62 | 1.79 | 1.62 | 1.40 | 1.03 | 1.39 | 0.24 | 0.00 |
| Diluted Shares Outstanding | 24.44M | 24.25M | 25.21M | 26.22M | 27.41M | 27.65M | 26.9M | 27.05M | 27.28M | 26.85M | 26.56M | 26.32M | 26.1M | 25.86M | 24.44M | 13.23M | 19.93M | 19.93M |
| Basic Shares Outstanding | 24.02M | 23.92M | 25.1M | 26.19M | 27.41M | 27.62M | 26.74M | 26.87M | 26.98M | 26.65M | 26.37M | 26.01M | 25.69M | 25.2M | 23.37M | 12.9M | 18.34M | 18.34M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying PRLB stock.
For fiscal year 2025, Proto Labs, Inc. (PRLB) reported total revenue of $533.1M. This represents a 1116.3% increase compared to $43.8M in 2009.
Proto Labs, Inc. (PRLB) is profitable, generating $21.2M in net income for the fiscal year ending 2025 with a net profit margin of 4.0%.
Proto Labs, Inc. (PRLB) reported an operating income of $26.2M, resulting in an operating profit margin of 4.9%. This margin reflects the operational efficiency of the business before interest and taxes.
Proto Labs, Inc. (PRLB) generated $237.1M in gross profit for the year, representing a gross profit margin of 44.5%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Thin operating margin sensitivity
Metrics are mathematically derived from official filings.
Re-Accelerating Top-Line Growth Momentum
According to reported quarterly figures, PRLB revenue grew 14.0% year over year to $154.3M in 2026Q3, a notable acceleration from the negative growth of -1.3% and -2.6% seen across early 2025 and late 2024, suggesting a meaningful reversal in demand trajectory.
The sequence from roughly flat to negative growth through 2025 followed by three consecutive quarters of double-digit expansion suggests a recovery in customer engagement rather than a single-period anomaly. Investors should determine whether the acceleration reflects broad-based volume recovery or a narrower lift from larger strategic accounts, since the reported data does not isolate segment-level contribution. Durability will depend on whether this pace holds once comparisons toward the prior-year base become more demanding.
Gross Margin Recovery Outpacing Operating Gains
Based on reported figures, PRLB gross margin expanded from 42.7% in 2024Q4 to 44.5% in 2026Q3, while operating margin reached 9.4% in the latest quarter versus 3.4% at the 2024Q4 trough, indicating pricing and mix contributed to profitability.
Gross margin has held within a relatively tight 44% to 46% band over the recent period, implying that the core pricing structure remains stable despite input cost variability. The larger proportional expansion in operating margin points to operating leverage on a fixed-cost base of machines and software, rather than a structural gross margin improvement. This dynamic appears sensitive to volume continuity, so a revenue slowdown could compress the leverage that has driven recent gains.
Operating Leverage Driving Earnings Scale
As reported in financial statements, PRLB operating income rose from $4.1M in 2024Q4 to $14.4M in 2026Q3 on revenue growth of roughly 27%, implying operating income scaled roughly three times faster than the top line over the period.
SG&A has remained near $42M to $45M per quarter while revenue expanded, which suggests overhead has been held largely flat and absorbed incremental gross profit. This pattern indicates favorable operating leverage, though it also means earnings are highly sensitive to revenue fluctuations given the largely fixed cost base. Investors may wish to monitor whether SG&A growth remains contained as the company scales its digital platform and sales initiatives.
Net Income Gains Partly Tied to Equity Compensation
Based on reported figures, PRLB stock-based compensation ran between $3.2M and $4.3M per quarter, representing a material share of operating income in several periods, which warrants consideration when assessing the durability of reported EPS growth.
Reported EPS of $0.48 in 2026Q3 is accompanied by a net margin of 7.6%, a rise that appears consistent with operating improvement rather than obvious non-operating distortions. The recurring SBC charge is a real cost of attracting engineering talent and should be treated as such when comparing GAAP earnings to non-GAAP figures. The quarterly EPS volatility, including the negative result in 2024Q4, suggests earnings remain sensitive to timing items that warrant further investigation.
Thin Margins Leave Little Cushion
The reported 9.4% operating margin in 2026Q3 remains modest for a business with a 44% gross margin, suggesting that a relatively small revenue shortfall or cost increase could erode the recent earnings recovery quickly.
The gap between gross margin near 44% and operating margin below 10% indicates that a substantial share of gross profit is consumed by R&D and SG&A, which may limit flexibility in a downturn. The reported figures do not show whether the recent growth is repeatable, and the 2025 period demonstrates how quickly growth can turn negative. Short-side scrutiny would likely center on whether margin expansion is sustainable or reflects temporary volume and mix benefits.